See the DrugPatentWatch profile for januvia
The trade name for the diabetes medication sitagliptin in Mexico is Januvia. [1]
What is Januvia used for?
Januvia is prescribed to improve glycemic control in adults with type 2 diabetes mellitus. It is often used in conjunction with diet and exercise. [1]
How does Januvia work?
Januvia is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by increasing the levels of incretin hormones, which are naturally produced by the body. These hormones help to regulate blood sugar by increasing insulin release and decreasing the amount of sugar produced by the liver. [2]
When does the patent for Januvia expire in Mexico?
Information regarding the specific patent expiry dates for Januvia in Mexico is not readily available. However, patent information for pharmaceuticals can be complex and may involve multiple patents covering different aspects of the drug, such as the active ingredient, formulation, and methods of use. [3] The drug patent landscape can be tracked through resources like DrugPatentWatch.com. [4]
Who makes Januvia?
Januvia is manufactured by Merck & Co., Inc., known as MSD outside the United States and Canada. [5]
What are the alternatives to Januvia for type 2 diabetes?
Several classes of medications are available for managing type 2 diabetes, offering alternatives to Januvia. These include metformin, sulfonylureas, thiazolidinediones (TZDs), SGLT2 inhibitors, GLP-1 receptor agonists, and insulin. The choice of medication depends on individual patient factors, including disease severity, comorbidities, and treatment goals. [2]